Literature DB >> 27505281

Molecular epidemiology of enterovirus and parechovirus infections according to patient age over a 4-year period in Spain.

María Cabrerizo1, María Díaz-Cerio1, Carmen Muñoz-Almagro2, Núria Rabella3, David Tarragó1, María Pilar Romero4, María José Pena5, Cristina Calvo6, Sonia Rey-Cao7, Antonio Moreno-Docón8, Inés Martínez-Rienda9, Almudena Otero1, Gloria Trallero1.   

Abstract

The epidemiology and clinical association of enterovirus (EV) and parechovirus (HPeV) infections, as well as the type-distribution-according-to-age, were determined during a 4-year study period in Spain. During 2010-2013, a total of 21,832 clinical samples were screened for EV and the detection frequency was 6.5% (1,430). Of the total EV-negative samples, only 1,873 samples from 2011 to 2013 were available for HPeV testing. HPeV was detected in 42 (2%) of them. Positive samples were genotyped using PCR and sequencing. EV infections occurred in all age groups of patients: neonates (17%), children 28 days to 2 years (29%), children 2-14 years (40%), and adults (14%). Thirty-four different EV types were identified. HPeV infections were detected exclusively in infants <8 m (70% neonates, P < 0.05). All but one HPeV were HPeV-3. Differences in type frequency detection were found according to age and clinical manifestation. Coxsackievirus (CV)-B4 (61%), CV-B5 (83%), and HPeV-3 (64%) were more frequent in neonates than in older patients (P < 0.05). Echovirus (E)-3 (60%), E-18 (47%), E-25 (62%), CV-A6 (61%), CV-A16 (72%), and EV-71 (75%) were mainly detected in children 28 days to 2 years (P < 0.05), whereas, E-6 (79%), E-20 (88%), and E-30 (85%) were predominant in children >2 years and adults (P < 0.05). Clinically, meningitis was associated with EV (P < 0.01) whereas, encephalitis was more frequent in HPeV-infected patients. CV-B types were associated with myocarditis (90%; P < 0.05) and EV species A with hand-foot-mouth-disease/atypical exanthema (88%; P < 0.05). J. Med. Virol. 89:435-442, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  enterovirus; epidemiology; immunity/immunization; nervous system; pathogenesis; virus classification

Mesh:

Year:  2016        PMID: 27505281     DOI: 10.1002/jmv.24658

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

1.  A 5-year study of human parechoviruses in children living in bad sanitation conditions and non-polio acute flaccid paralysis children from Greece.

Authors:  Karageorgou Ioulia; Pogka Vasiliki; Labropoulou Stavroula; Angelakis Emmanouil; Mentis Andreas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-16       Impact factor: 3.267

2.  Surveillance for Enteroviruses Associated with Hand, Foot, and Mouth Disease, and Other Mucocutaneous Symptoms in Spain, 2006-2020.

Authors:  Nieves Martínez-López; Carmen Muñoz-Almagro; Cristian Launes; Ana Navascués; Manuel Imaz-Pérez; Jordi Reina; María Pilar Romero; Cristina Calvo; Montserrat Ruiz-García; Gregoria Megias; Juan Valencia-Ramos; Almudena Otero; María Cabrerizo
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

3.  Human parechovirus meningitis and gross-motor neurodevelopment in young children.

Authors:  Ted M T van Hinsbergh; Stephanie C M de Crom; Robert Lindeboom; Marceline A M van Furth; Charlie C Obihara
Journal:  Eur J Pediatr       Date:  2019-01-14       Impact factor: 3.860

4.  Contribution of Enteroviruses to Acute Central Nervous System or Systemic Infections in Northern Italy (2015-2017): Is It Time to Establish a National Laboratory-Based Surveillance System?

Authors:  Antonio Piralla; Laura Pellegrinelli; Federica Giardina; Cristina Galli; Sandro Binda; Elena Pariani; Fausto Baldanti
Journal:  Biomed Res Int       Date:  2020-07-01       Impact factor: 3.411

5.  Molecular epidemiology of an enterovirus A71 outbreak associated with severe neurological disease, Spain, 2016.

Authors:  Rubén González-Sanz; Didac Casas-Alba; Cristian Launes; Carmen Muñoz-Almagro; María Montserrat Ruiz-García; Mercedes Alonso; María José González-Abad; Gregoria Megías; Nuria Rabella; Margarita Del Cuerpo; Mónica Gozalo-Margüello; Alejandro González-Praetorius; Ana Martínez-Sapiña; María José Goyanes-Galán; María Pilar Romero; Cristina Calvo; Andrés Antón; Manuel Imaz; Maitane Aranzamendi; Águeda Hernández-Rodríguez; Antonio Moreno-Docón; Sonia Rey-Cao; Ana Navascués; Almudena Otero; María Cabrerizo
Journal:  Euro Surveill       Date:  2019-02

6.  Surveillance of enteroviruses from paediatric patients attended at a tertiary hospital in Catalonia from 2014 to 2017.

Authors:  Cristina Andrés; Jorgina Vila; Laura Gimferrer; Maria Piñana; Juliana Esperalba; Maria Gema Codina; Meritxell Barnés; Maria Carmen Martín; Francisco Fuentes; Susana Rubio; Pilar Alcubilla; Carlos Rodrigo; Tomàs Pumarola; Andrés Antón
Journal:  J Clin Virol       Date:  2018-11-30       Impact factor: 3.168

Review 7.  Dilated cardiomyopathy.

Authors:  Heinz-Peter Schultheiss; DeLisa Fairweather; Alida L P Caforio; Felicitas Escher; Ray E Hershberger; Steven E Lipshultz; Peter P Liu; Akira Matsumori; Andrea Mazzanti; John McMurray; Silvia G Priori
Journal:  Nat Rev Dis Primers       Date:  2019-05-09       Impact factor: 65.038

8.  Enteroviruses in Respiratory Samples from Paediatric Patients of a Tertiary Care Hospital in Germany.

Authors:  Susanne Baertl; Corinna Pietsch; Melanie Maier; Mario Hönemann; Sandra Bergs; Uwe G Liebert
Journal:  Viruses       Date:  2021-05-11       Impact factor: 5.048

9.  Clinical features and seasonality of parechovirus infection in an Asian subtropical city, Hong Kong.

Authors:  Grace P K Chiang; Zigui Chen; Martin C W Chan; Simon H M Lee; Angela K Kwok; Apple C M Yeung; E Anthony S Nelson; Kam Lun Hon; Ting Fan Leung; Paul K S Chan
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

10.  VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment.

Authors:  Fang-Hong Chen; Xiong Liu; Hua-Li Fang; Nan Nan; Zhan Li; Nian-Zhi Ning; De-Yan Luo; Tao Li; Hui Wang
Journal:  Front Immunol       Date:  2019-11-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.